MYUNGMOON Pharm co.,Ltd reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was KRW 35,198.77 million compared to KRW 32,151.4 million a year ago. Net loss was KRW 133.82 million compared to KRW 4,804.99 million a year ago. Basic loss per share from continuing operations was KRW 4 compared to KRW 174 a year ago. Basic loss per share was KRW 4 compared to KRW 174 a year ago. For the nine months, sales was KRW 5,324.23 million compared to KRW 4,353.15 million a year ago. Net income was KRW 1,140.73 million compared to net loss of KRW 19,667.73 million a year ago. Basic earnings per share from continuing operations was KRW 34 compared to basic loss per share from continuing operations of KRW 709 a year ago. Basic earnings per share was KRW 34 compared to basic loss per share of KRW 709 a year ago.